Advanced Medical Solutions Group plc Share Price
Stocks
AMS
GB0004536594
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 214.00 GBX | -2.95% |
|
-1.38% | -1.83% |
| 26/05 | H.B. Fuller Shareholder Ancora Opposes Proposed Acquisition of Advanced Medical Solutions | MT |
| 26/05 | Activist Shareholder Urges HB Fuller to Withdraw Advanced Medical Solutions Takeover Bid | MT |
| Market Cap | 46Cr 62Cr 54Cr 49Cr 87Cr 5.91TCr 88Cr 584.24Cr 227.79Cr 2.88TCr 233.31Cr 228.35Cr 9.96TCr | P/E Ratio 2026 * |
31.2x | P/E Ratio 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 51Cr 68Cr 59Cr 54Cr 95Cr 6.45TCr 96Cr 637.39Cr 248.51Cr 3.14TCr 254.54Cr 249.12Cr 11TCr | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.82x |
| Free-Float |
95.21% | Yield 2026 * |
1.49% | Yield 2027 * | 1.7% |
| 24/12 | RBC Lifts Advanced Medical Solutions PT, Keeps Outperform Rating | MT |
| 28/25/28 | Berkeley and Advanced Medical Solutions raised | AN |
| 25/25/25 | UK banks get price target upgrades | AN |
| 03/24/03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
| 28/24/28 | Aviva and L&G cut; mixed calls on Diploma | AN |
| 1 day | -2.95% | ||
| 1 week | -1.38% | ||
| Current month | -2.28% | ||
| 1 month | -14.06% | ||
| 3 months | +10.42% | ||
| 6 months | +2.88% | ||
| Current year | -1.83% |
| 1 week | 210 | 227 | |
| 1 month | 187 | 256.5 | |
| Current year | 187 | 272 | |
| 1 year | 187 | 272 | |
| 3 years | 165.6 | 275.83 | |
| 5 years | 165.6 | 347 | |
| 10 years | 165.6 | 374 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Meredith
CEO | Chief Executive Officer | 60 | 01/01/2011 |
Edward Johnson
DFI | Director of Finance/CFO | 54 | 01/01/2019 |
| Chief Operating Officer | - | 01/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Meredith
BRD | Director/Board Member | 60 | 01/01/2011 |
Edward Johnson
BRD | Director/Board Member | 54 | 01/01/2019 |
Grahame Cook
CHM | Chairman | 68 | 31/03/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/25/08 | Buy | Chief Financial Officer | 9,040 | 0.0041% | ||
| 08/25/08 | Sell | Chief Financial Officer | 18,726 | 0.0086% | ||
| 08/25/08 | Buy | Chief Financial Officer | 9,546 | 0.0044% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.95% | -1.38% | +0.47% | -10.08% | 64Cr | ||
| +1.75% | -0.21% | -40.10% | -55.51% | 1.31TCr | ||
| -2.53% | -3.12% | +93.23% | +104.17% | 442.13Cr | ||
| +1.82% | +6.79% | +325.02% | +170.20% | 327.25Cr | ||
| +1.23% | -1.13% | -43.52% | -35.07% | 237.63Cr | ||
| +0.30% | +0.60% | -45.22% | -69.98% | 194.13Cr | ||
| -3.01% | -1.23% | +0.62% | -26.82% | 163.62Cr | ||
| -1.53% | +0.78% | -29.51% | -43.91% | 109.75Cr | ||
| +0.58% | -0.57% | +20.98% | +44.17% | 99Cr | ||
| -2.73% | -3.60% | +75.41% | +18.89% | 92Cr | ||
| Average | -0.71% | +0.22% | +35.74% | +9.60% | 303.55Cr | |
| Weighted average by Cap. | +0.35% | -0.25% | +27.02% | +1.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25Cr 33Cr 29Cr 26Cr 46Cr 3.14TCr 47Cr 310.42Cr 121.03Cr 1.53TCr 123.96Cr 121.33Cr 5.29TCr | 26Cr 35Cr 31Cr 28Cr 49Cr 3.37TCr 50Cr 333.14Cr 129.89Cr 1.64TCr 133.04Cr 130.21Cr 5.68TCr |
| Net income | 1.44Cr 1.93Cr 1.66Cr 1.53Cr 2.69Cr 183.08Cr 2.73Cr 18Cr 7.06Cr 89Cr 7.23Cr 7.08Cr 308.56Cr | 2.59Cr 3.48Cr 3Cr 2.77Cr 4.85Cr 330.44Cr 4.93Cr 33Cr 13Cr 160.84Cr 13Cr 13Cr 556.91Cr |
| Net Debt | 4.21Cr 5.66Cr 4.88Cr 4.5Cr 7.9Cr 537.59Cr 8.02Cr 53Cr 21Cr 261.66Cr 21Cr 21Cr 906.01Cr | 1.67Cr 2.24Cr 1.94Cr 1.79Cr 3.13Cr 213.2Cr 3.18Cr 21Cr 8.22Cr 103.77Cr 8.42Cr 8.24Cr 359.31Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 214.00 p | -2.95% | 12,68,463 |
| 11/26/11 | 220.50 p | -1.34% | 11,35,370 |
| 10/26/10 | 223.50 p | +2.05% | 9,24,825 |
| 09/26/09 | 219.00 p | 0.00% | 10,29,184 |
| 08/26/08 | 219.00 p | +0.92% | 12,92,637 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















